Delivery Order SPE2DB20D2104-SPE2DB25FMLEG
Award Date
3/17/25
Potential Completion Date
3/18/25
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML. The $71,858.16 contract has an ultimate completion date of January 31, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $63,817.20 firm fixed-price delivery order is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $80,351.72 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML medication. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,100.08 firm fixed-price delivery order is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The contract has a completion date of September 27, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,070.75, is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medication used in the treatment of diabetes. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,548.32 firm fixed-price delivery order is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of June 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $14,501.52 and covers the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product, with a performance period through March 10, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,718.68, is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a diabetes medication. The order has an ultimate completion date of August 24, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $7,727.44 firm fixed price delivery order contract for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
This federal contract award, valued at $2,969.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, with a completion date of November 16, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...